ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

BIOM Biomira Inc. - Common Shares (MM)

0.00
0.00 (0.00%)
Last Updated: -
Delayed by 15 minutes
Share Name Share Symbol Market Type
Biomira Inc. - Common Shares (MM) NASDAQ:BIOM NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0 -

Biomira Inc - Report of Foreign Issuer (6-K)

17/10/2007 9:14pm

Edgar (US Regulatory)


 

FORM 6-K

 

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

Report of Foreign Issuer

Pursuant to Rule 13a-16 or 15d-16 of

the Securities Exchange Act of 1934

 

Dated October 17, 2007

 

BIOMIRA INC.
(Translation of registrant’s name into English)

 

Edmonton Research Park
2011-94 Street, Edmonton, Alberta Canada T6N1H1

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

 

Form 20-F x

 

Form 40-F x

(for past years ending in calendar year 1996)

 

(commencing in calendar year 1997)

 

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

 

Yes o

 

No x

 

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):       

 

 

 



 

EXPLANATORY NOTE

 

On October 12, 2007, Biomira Inc. (“Biomira”) filed with the System for Electronic Document Analysis and Retrieval in Canada (“SEDAR”) the following document, which relates to the transcript and slides of a presentation made to the Bio InvestorForum 2007, by Robert Kirkman, M.D., Biomira’s President and Chief Executive Officer. A copy of the presentation transcript and accompanying slides are attached to this report as Exhibit 1.

 

2



 

EXHIBIT INDEX

 

Exhibit
Number

 

Description of Document

 

 

 

1

 

Presentation transcript and accompanying slides made to the Bio InvestorForum 2007, which is incorporated by reference from Biomira Inc. and Oncothyreon Inc.’s Rule 425 submission filed with the Securities and Exchange Commission on October 11, 2007.

 

3



 

SIGNATURES

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

BIOMIRA INC.

 

(Registrant)

 

 

 

 

Date: October 17, 2007

By:

/s/ Edward A. Taylor

 

 

Edward A. Taylor

 

 

Vice President, Finance & Administration and
Chief Financial Officer

 

4


1 Year Biomira Inc. - Common Shares (MM) Chart

1 Year Biomira Inc. - Common Shares (MM) Chart

1 Month Biomira Inc. - Common Shares (MM) Chart

1 Month Biomira Inc. - Common Shares (MM) Chart